FORMATION OF NON-CYCLOOXYGENASE-DERIVED PROSTANOIDS (F-2-ISOPROSTANES) IN PLASMA AND LOW-DENSITY-LIPOPROTEIN EXPOSED TO OXIDATIVE STRESS IN-VITRO

被引:208
作者
LYNCH, SM
MORROW, JD
ROBERTS, LJ
FREI, B
机构
[1] HARVARD UNIV,SCH PUBL HLTH,DEPT NUTR,BOSTON,MA 02115
[2] HARVARD UNIV,SCH PUBL HLTH,DEPT MOLEC & CELLULAR TOXICOL,BOSTON,MA 02115
[3] VANDERBILT UNIV,DEPT PHARMACOL,NASHVILLE,TN 37232
[4] VANDERBILT UNIV,DEPT MED,NASHVILLE,TN 37232
关键词
ATHEROSCLEROSIS; FREE RADICALS; LIPID PEROXIDATION; ANTIOXIDANTS; EICOSANOIDS;
D O I
10.1172/JCI117107
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
F-2-isoprostanes are prostaglandin F-2-like compounds that are known to be formed in vivo by free radical oxidation of arachidonyl-containing lipids, and their plasma levels have been suggested as indicators of in vivo oxidative stress. As oxidation of LDL, a likely causal factor in atherosclerosis, involves lipid peroxidation, we investigated whether F-2-isoprostanes are formed in plasma and LDL exposed to oxidative stress, and how F-2-isoprostane formation is related to endogenous antioxidant status. In plasma exposed to aqueous peroxyl radicals, lipid hydroperoxides and esterified F-2-isoprostanes were formed simultaneously after endogenous ascorbate and ubiquinol-10 had been exhausted, despite the continued presence of urate, alpha-tocopherol, beta-carotene, and lycopene. In isolated LDL exposed to aqueous peroxyl radicals or Cu2+, consumption of endogenous ubiquinol-10 and alpha-tocopherol was followed by rapid formation and subsequent breakdown of lipid hydroperoxides and esterified F-2-isoprostanes, and a continuous increase in LDL's electronegativity, indicative of atherogenic modification. In Cu2+-exposed LDL, the decrease in esterified F-2-isoprostane levels was paralleled by the appearance of free F-2-isoprostanes, suggesting that hydrolysis by an LDL-associated activity had occurred. Our data suggest that F-2-isoprostanes are useful markers of LDL oxidation in vivo. As F-2-isoprostanes are potent vasoconstrictors and can modulate platelet aggregation, their formation in LDL demonstrated here may also have important implications for the etiology of cardiovascular disease.
引用
收藏
页码:998 / 1004
页数:7
相关论文
共 49 条
  • [1] EFFECTS OF A NOVEL PROSTAGLANDIN, 8-EPI-PGF2-ALPHA, IN RABBIT LUNG INSITU
    BANERJEE, M
    KANG, KH
    MORROW, JD
    ROBERTS, LJ
    NEWMAN, JH
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (03): : H660 - H663
  • [2] VITAMIN-E IN HUMAN LOW-DENSITY-LIPOPROTEIN - WHEN AND HOW THIS ANTIOXIDANT BECOMES A PROOXIDANT
    BOWRY, VW
    INGOLD, KU
    STOCKER, R
    [J]. BIOCHEMICAL JOURNAL, 1992, 288 : 341 - 344
  • [3] MONOCYTES AND NEUTROPHILS OXIDIZE LOW-DENSITY LIPOPROTEIN MAKING IT CYTO-TOXIC
    CATHCART, MK
    MOREL, DW
    CHISOLM, GM
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1985, 38 (02) : 341 - 350
  • [4] CHUNG BH, 1986, METHOD ENZYMOL, V128, P181
  • [5] MINIMALLY MODIFIED LOW-DENSITY-LIPOPROTEIN INDUCES MONOCYTE CHEMOTACTIC PROTEIN-1 IN HUMAN ENDOTHELIAL-CELLS AND SMOOTH-MUSCLE CELLS
    CUSHING, SD
    BERLINER, JA
    VALENTE, AJ
    TERRITO, MC
    NAVAB, M
    PARHAMI, F
    GERRITY, R
    SCHWARTZ, CJ
    FOGELMAN, AM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) : 5134 - 5138
  • [6] ANTIOXIDANT AND CO-ANTIOXIDANT ACTIVITY OF VITAMIN-C - THE EFFECT OF VITAMIN-C, EITHER ALONE OR IN THE PRESENCE OF VITAMIN-E OR A WATER-SOLUBLE VITAMIN-E ANALOG, UPON THE PEROXIDATION OF AQUEOUS MULTILAMELLAR PHOSPHOLIPID LIPOSOMES
    DOBA, T
    BURTON, GW
    INGOLD, KU
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 835 (02) : 298 - 303
  • [7] DRAKE TA, 1991, AM J PATHOL, V138, P601
  • [8] THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL
    ESTERBAUER, H
    GEBICKI, J
    PUHL, H
    JURGENS, G
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) : 341 - 390
  • [9] ASCORBATE IS AN OUTSTANDING ANTIOXIDANT IN HUMAN-BLOOD PLASMA
    FREI, B
    ENGLAND, L
    AMES, BN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (16) : 6377 - 6381
  • [10] FREI B, 1990, ADV EXP MED BIOL, V264, P155